Japan: Examining the first biosimilar patent litigation

In Japan, effectiveness and efficacy have been observed in breast cancer where overexpression of HER 2 was seen and in unresectable advanced or recurrent gastric cancer where overexpression of HER 2 w…
( read original story …)


Related Post

Japan’s love of cash is a costly business
views 207
TOKYO -- If you go out for drinks with your collea...
Dismembered bodies, severed heads found inside coo...
views 309
Tokyo police have arrested a man after finding “mu...
Tokyo stocks open lower tracking Wall Street falls
views 143
Tokyo stocks opened lower on Wednesday tracking fa...
Japan starts weekend early to improve work-life ba...
views 368
TOKYO – It was not business as usual for some work...
Tokyo Electron Sees Potential Mid-Year Semiconduct...
views 22
(Bloomberg) -- Tokyo Electron Ltd., one of the wor...
Space X’s plan for 2020s: Tokyo to Delhi in 30 min...
views 224
“A trip from Bangkok to Dubai would take 27 minute...
Many Japan shares climb on solid earnings, though ...
views 64
TOKYO, July 26 (Reuters) - Most Japanese shares ga...
Matsui eyes second referendum on Osaka merger plan...
views 235
OSAKA – Osaka Gov. Ichiro Matsui announced Monday ...
Yahoo Japan is refusing to stop the sale of ivory ...
views 303
Ivory tusks are displayed after the official start...
China’s military is turning its aggressive S...
views 209
Additionally, China had never sent a submarine int...